Roche Perjeta regimen gets FDA priority review in breast cancer Ruby Khatun Khatun4 Oct 2017 9:20 AM ISTZURICH: The U.S. Food and Drug Administration (FDA) has granted a priority review for Roche's Perjeta in combination with Herceptin and chemotherapy...
Lupin gets USFDA nod for infection treating drug Ruby Khatun Khatun3 Oct 2017 10:45 AM ISTNew Delhi: Drug major Lupin said it has received approval from the US health regulator for its doxycycline hyclate tablets used for the treatment of...
Immunotherapy developer Dynavax explores options for Hepatitis B drug - sources Ruby Khatun Khatun3 Oct 2017 9:57 AM ISTDynavax Technologies Corporation, a biotechnology company focused on drugs that harness the immune system to combat disease, is reviewing strategic...
Eli Lilly names new CFO, replaces head of research and development in management shakeup Ruby Khatun Khatun3 Oct 2017 9:35 AM ISTNEW YORK: Eli Lilly and Co named a new chief financial officer and replaced the head of its research and development arm, among other changes to its...
Shire sues Allergan in US over dry eye drug Ruby Khatun Khatun3 Oct 2017 9:15 AM ISTAllergan Plc was sued on Monday by Shire Plc for allegedly scheming to block doctors from prescribing its new treatment for dry eye disease.In a...
Pfizer Spins Out Biotech Firm With 103 Million dollar In Funding Ruby Khatun Khatun2 Oct 2017 10:29 AM ISTIn keeping with a trend of smaller firms raising buckets of cash using Big Pharma's cast-off drugs, Pfizer Inc. is adapting the strategy for itself by...
Abbott wins US antitrust approval to buy Alere with conditions Ruby Khatun Khatun2 Oct 2017 9:47 AM ISTWASHINGTON: Abbott Laboratories has won U.S. antitrust approval to buy Alere Inc on condition that it sells two point-of-care medical testing...
Merck KGaA eyes up to 700 million euro Mavenclad sales in EU Ruby Khatun Khatun2 Oct 2017 9:20 AM ISTFRANKFURT: Germany’s Merck KGaA is eyeing annual sales of its multiple sclerosis pill Mavenclad, a late-comer to the market for oral treatments...
Spire Healthcare appoints Justin Ash as CEO Ruby Khatun Khatun2 Oct 2017 9:00 AM ISTBritain’s second-largest healthcare firm Spire Healthcare Group Plc on Wednesday appointed former Oasis Healthcare CEO Justin Ash as its chief...
Eli Lilly gets FDA approval for breast cancer drug Ruby Khatun Khatun1 Oct 2017 10:30 AM ISTThe U.S. Food and Drug Administration (FDA) said on Thursday it approved an Eli Lilly and Co drug to treat advanced breast cancer that has progressed...
AbbVie, Amgen settlement sets Humira US biosimilar launch for 2023 Ruby Khatun Khatun1 Oct 2017 10:01 AM ISTAmgen Inc has reached a settlement with AbbVie Inc that will delay the U.S. launch of Amgen’s cheaper biosimilar version of AbbVie’s cash cow, the...
EU approves Sanofi and Regenerons dupilumab in eczema Ruby Khatun Khatun1 Oct 2017 9:45 AM ISTPARIS: The European Commission approved Regeneron Pharmaceuticals’ and Sanofi’s key biologic treatment dupilumab for moderate-to-severe atopic...
